HLB Therapeutics Co.,Ltd.
115450
Classificação em ações
#18248
HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the... HLB Therapeutics Co.,Ltd. operates as a biotechnology company, focusing on the creation of pharmaceutical products for both the South Korean and international markets. A significant part of its research and development initiatives includes GBT-201, a compound utilizing Thymosin beta designed to treat various eye ailments such as dry eye syndrome and neurotrophic keratopathy. Additionally, the company is advancing OKN-007 as a potential therapy for glioblastoma brain tumors. Beyond its pharmaceutical endeavors, HLB Therapeutics is also involved in the wholesale distribution of vaccines and the production of electrical and electronic components like motors, pumps, and transformers. The company, which established its roots in 2000 and is based in Seongnam, South Korea, underwent a name change in December 2021, transitioning from its former identity as G-treeBNT Co., Ltd. to its current designation.
Preço da ação
$2.02
Valor de mercado
$190.66M
Variação (1 dia)
7.96%
Variação (1 ano)
-1.16%
País
KR
Negociar HLB Therapeutics Co.,Ltd. (115450)
Categoria
Healthcare
Histórico de preços das ações de HLB Therapeutics Co.,Ltd. (115450)
Preço de fecho mais alto: $1.94 em 2026-10-01
Preço de fecho mais baixo: $9.82 em 2010-03-01
Preço de fecho mais baixo: $9.82 em 2010-03-01
Histórico de preços das ações da HLB Therapeutics Co.,Ltd. de 2010 a 2026
Desempenho anual do preço das ações
| Ano | Desempenho |
|---|---|
| 2026 (TTM) | -4.53% |
| 2025 | -69.48% |
| 2024 | 142.67% |
| 2023 | -24.36% |
| 2022 | -34.28% |
| 2021 | -50.71% |
| 2020 | 1.61% |
| 2019 | 7.70% |
| 2018 | -17.13% |
| 2017 | 106.04% |
| 2016 | 24.88% |
| 2015 | 254.54% |
| 2014 | 20.37% |
| 2013 | -14.85% |
| 2012 | -28.46% |
| 2011 | -62.15% |
| 2010 | 0.00% |
Preço das ações de empresas similares ou concorrentes
| Empresa | Preço da ação | Variação 1a% | País |
|---|---|---|---|
| $536.13 | 25.72% |
US
|
|
| $200.12 | 645.31% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $291.76 | 2.51% |
BE
|
|
| $880.01 | 8.09% |
NL
|
